[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) is a global medical technology company that develops, manufactures, and markets minimally invasive medical devices. With a market capitalization of approximately $68.5 billion, the company provides innovative solutions across cardiovascular, electrophysiology, endoscopy, urology, neuromodulation, and other medical specialties, serving healthcare providers and patients in more than 120 countries.

Shares of this medtech giant have significantly underperformed the broader market over the past year. BSX has declined 56.8% during this period, while the broader S&P 500 Index ($SPX) has rallied nearly 14.8%. Likewise, the stock is down 51.7% year-to-date, trailing the index's 6.9% gain over the same period.

Fundamentals

See More
  • Market Capitalization, $K 68,372,328
  • Shares Outstanding, K 1,486,355
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,699 M
  • EBITDA $ 6,113 M
  • 60-Month Beta 0.58
  • Price/Sales 3.41
  • Price/Cash Flow 11.41
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 42.88% (+2.45%)
  • Historical Volatility 30.39%
  • IV Percentile 84%
  • IV Rank 63.43%
  • IV High 57.06% on 07/20/26
  • IV Low 18.29% on 12/09/25
  • Expected Move (DTE 6) 1.94 (4.15%)
  • Put/Call Vol Ratio 0.70
  • Today's Volume 38,704
  • Volume Avg (30-Day) 41,132
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 956,136
  • Open Int (30-Day) 861,643
  • Expected Range 44.79 to 48.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.80
  • Number of Estimates 5
  • High Estimate $0.81
  • Low Estimate $0.80
  • Prior Year $0.75
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.20 +10.73%
on 07/15/26
47.15 -0.90%
on 07/28/26
+4.05 (+9.49%)
since 06/30/26
3-Month
42.20 +10.73%
on 07/15/26
58.51 -20.13%
on 05/22/26
-10.88 (-18.89%)
since 04/30/26
52-Week
42.20 +10.73%
on 07/15/26
109.50 -57.32%
on 09/09/25
-60.03 (-56.23%)
since 07/30/25

Most Recent Stories

More News
Penumbra, Inc. Reports Second Quarter 2026 Financial Results

ALAMEDA, Calif. , July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026....

BSX : 46.73 (+1.59%)
PEN : 321.19 (+0.43%)
What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Boston Scientific underperformed the broader market, though analysts remain optimistic, citing strong earnings execution, innovation, and meaningful upside from current levels.

BSX : 46.73 (+1.59%)
$SPX : 7,489.72 (+0.70%)
IHI : 52.51 (-0.44%)
BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook

BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook

BSX : 46.73 (+1.59%)
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

BSX : 46.73 (+1.59%)
Boston Scientific: Q2 Earnings Snapshot

Boston Scientific: Q2 Earnings Snapshot

BSX : 46.73 (+1.59%)
Boston Scientific announces results for second quarter 2026

MARLBOROUGH, Mass. , July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported...

BSX : 46.73 (+1.59%)
Boston Scientific's Restructuring Bet Hinges on Whether Wednesday's Guidance Acknowledges the Trade-Off

Barchart Research What to Expect from BSX Earnings BSX Generated July 28, 2026 Current Price $46.06 EPS Estimate $$0.83 Consensus Rating Strong Buy Average Move 5.27% Boston Scientific's Restructuring...

BSX : 46.73 (+1.59%)
What To Expect From Boston Scientific’s (BSX) Q2 Earnings

What To Expect From Boston Scientific’s (BSX) Q2 Earnings

BSX : 46.73 (+1.59%)
Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.

BSX : 46.73 (+1.59%)
HCA : 402.59 (+1.72%)
MDT : 85.39 (-0.37%)
ISRG : 353.33 (+0.10%)
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?

Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?

BSX : 46.73 (+1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 49.91
2nd Resistance Point 48.36
1st Resistance Point 47.54
Last Price 46.73
1st Support Level 45.17
2nd Support Level 43.62
3rd Support Level 42.80

See More

52-Week High 109.50
Fibonacci 61.8% 83.79
Fibonacci 50% 75.85
Fibonacci 38.2% 67.91
Last Price 46.73
52-Week Low 42.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.